Cocrystal Pharma, Inc.·4

Oct 30, 4:15 PM ET

PFENNIGER RICHARD C JR 4

4 · Cocrystal Pharma, Inc. · Filed Oct 30, 2025

Insider Transaction Report

Form 4
Period: 2025-10-28
Transactions
  • Award

    Warrants

    2025-10-28$1.39/sh+40,000$55,60040,000 total
    Exercise: $1.24Exp: 2028-01-28Common Stock (40,000 underlying)
  • Award

    Common Stock

    2025-10-28+20,00031,400 total
Footnotes (2)
  • [F1]The Reporting Person purchased units at $1.39 per unit with each unit consisting of one share of common stock and a warrant to purchase two shares of common stock.The shares of common stock and warrants purchased are exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by a Special Committee of the Board of Directors of the Issuer, which Special Committee consisted of two non-employee directors. The warrants were exercisable upon issuance.
  • [F2]Includes shares of common stock issuable upon vesting of restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4